____________________________________________________________________________________________________________
STADA individual products having been introduced in STADA’ s financial year ended 31 December 31, 2024. Furthermore, a solid pipeline of new products provides the commercial network with further opportunities as markets grow.
In developing, manufacturing and distributing its products, STADA relies on approximately 11,650 employees around the world. With a strong track record of growth, both organically and through targeted acquisitions, the group aims to expand its business and further improve profitability by rolling-out successful developments or in-licensed products internationally, growing its business segments and driving economies of scale.
STADA’ s historical roots can be traced back to a pharmacist’ s cooperative founded in 1895 in Dresden, Germany, when a group of pharmacists started manufacturing pharmaceutical products under the name
STADA’ s historical roots can be traced back to a pharmacist’ s cooperative founded in 1895...
Standardarzneimittel Deutscher Apotheker. Over the course of 130 years, the company has successfully expanded from a small pharmaceutical undertaking focused on its domestic German market into a leading player in the international healthcare and pharmaceutical markets. In the financial year ended 31 December 2024, STADA generated group revenues of € 4.06 billion, and adjusted constant-currency EBITDA of € 886 million. ■
www. stada. com manufacturing-today. com 107